Parrish Capital LLC

Position in ABBV — AbbVie Inc.

CIK 2131053 KENNESAW, GA

Position in ABBV

as of Mar 31, 2026 · filed Apr 28, 2026 Compact

Position Value

$1,709,906

-$182,905 QoQ

Shares Held

7,862

-5.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.54%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Parrish Capital LLC holds $8,791,854 across 4 Drug Manufacturers - General names. ABBV ranks #3 (19.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	22,746	$3,170,110
2	AZN	Astrazeneca PLC	11,555	$2,278,877
3	ABBV	AbbVie Inc. This page	7,862	$1,709,906
4	GSK	GSK plc	29,588	$1,632,961

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,709,906	7,862	-5.1%	Shares	Sole	2026-04-28
2025-12-31	$1,892,811	8,284	—	Shares	Sole	2026-04-28
No filing history on record for this holder in this stock.